Shaleh, Hassan
Mayo Clinic
Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, MN, USA.
Citations 1
Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells
Ding, Xiwei , Chaiteerakij, Roongruedee , Moser, Catherine D., Shaleh, Hassan M., Boakye, Jeffrey, Ndzengue, Albert, Zhou, Yanling , Huang, Shengbing, Thomas, Melanie B., Smith, Charles D. , Roberts, Lewis R. , Shaleh, Hassan, Chen, Gang , Chaiteerakij, Roongruedee , Li, Ying , Sinicrope, Frank A. , Zou, Xiaoping , Roberts, Lewis R
Oncotarget | March 4, 2016 | Volume: 7 | Issue: 15 | Pages: 20080-20092
